Time：2024-10-15 09:31:28 View:
From October 5th to 9th, 2024, Luo Yifan, a student representative from Professor Han-Lu's team at Nanjing Medical University, traveled to Chicago, USA, to attend the 53rd Annual Meeting of the American Neuroscience Society (Neuroscience 2024). This conference is hosted by the American Neuroscience Society and aims to bring together scientists from diverse professional backgrounds. To enhance understanding of the brain and nervous system, a total of 24 plenary sessions and nearly 100 sub-session special reports were set up. More than 20,000 experts and scholars in the field of neuroscience from all over the world attended this conference, providing an important platform for international neuroscientists to exchange and learn.
Members of the research group actively participated in this academic conference, focusing on areas such as neural circuits, neuropharmacology, and new drug targets. On the afternoon of October 7th, Luo Yifan gave an all-English oral presentation on the research work of his research group in revealing the different downward circuits of the medial prefrontal cortex projecting to the striatum and amygdala respectively regulating autism-like and anxiest-like behaviors. In the poster display area, he engaged in a lively discussion with experts and scholars from various fields of neuroscience around the world on topics such as negative emotion-related diseases, neurodevelopment-related diseases, and aging-related diseases, from the perspectives of genomics, neural circuits, neurovascular units, and cross-organ interactions. This strengthened academic exchanges and promoted the cross-disciplinary and integrated development.
This conference provided the students of the research group with a valuable opportunity to exchange ideas with internationally renowned experts and scholars. It also inspired the relevant students to continuously deepen their understanding and recognition of the cutting-edge fields of neuroscience, and contribute their own wisdom and strength to promoting the discovery of drug targets for major brain diseases and the development of innovative drugs.